Regentatlantic Capital LLC Baxter International Inc Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Baxter International Inc stock. As of the latest transaction made, Regentatlantic Capital LLC holds 17,723 shares of BAX stock, worth $613,924. This represents 0.03% of its overall portfolio holdings.

Number of Shares

17,723

Previous 20,711 14.43%

Holding current value

$613,924

Previous $1.33 Million 28.2%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $160,933 - $199,598	-2,988 Reduced 14.43%	17,723 $955,000
Q2 2022 Aug 15, 2022	SELL	$63.83 - $80.0 $148,149 - $185,680	-2,321 Reduced 10.08%	20,711 $1.33 Million
Q1 2022 May 02, 2022	SELL	$76.85 - $89.45 $181,750 - $211,549	-2,365 Reduced 9.31%	23,032 $1.79 Million
Q4 2021 Jan 27, 2022	SELL	$74.57 - $87.19 $128,334 - $150,053	-1,721 Reduced 6.35%	25,397 $2.18 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $101,728 - $115,298	1,379 Added 5.36%	27,118 $2.18 Million
Q2 2021 Aug 12, 2021	BUY	$80.5 - $88.01 $5,635 - $6,160	70 Added 0.27%	25,739 $2.07 Million
Q1 2021 Apr 29, 2021	BUY	$76.38 - $86.03 $183,846 - $207,074	2,407 Added 10.35%	25,669 $2.17 Million
Q4 2020 Feb 04, 2021	SELL	$75.39 - $82.36 $56,768 - $62,017	-753 Reduced 3.14%	23,262 $1.87 Million
Q3 2020 Oct 13, 2020	SELL	$78.33 - $90.73 $40,888 - $47,361	-522 Reduced 2.13%	24,015 $1.93 Million
Q2 2020 Aug 13, 2020	BUY	$78.66 - $94.14 $201,762 - $241,469	2,565 Added 11.67%	24,537 $2.11 Million
Q1 2020 May 14, 2020	SELL	$71.57 - $93.3 $50,242 - $65,496	-702 Reduced 3.1%	21,972 $1.78 Million
Q4 2019 Feb 04, 2020	SELL	$76.7 - $88.45 $2,224 - $2,565	-29 Reduced 0.13%	22,674 $1.9 Million
Q3 2019 Oct 22, 2019	SELL	$81.4 - $89.78 $91,656 - $101,092	-1,126 Reduced 4.73%	22,703 $1.99 Million
Q2 2019 Jul 23, 2019	SELL	$73.44 - $82.41 $19,902 - $22,333	-271 Reduced 1.12%	23,829 $1.95 Million
Q1 2019 May 03, 2019	SELL	$64.48 - $81.31 $193 - $243	-3 Reduced 0.01%	24,100 $1.96 Million
Q4 2018 Jan 30, 2019	BUY	$61.45 - $77.8 $2,273 - $2,878	37 Added 0.15%	24,103 $1.59 Million
Q3 2018 Oct 30, 2018	SELL	$70.71 - $77.75 $121,479 - $133,574	-1,718 Reduced 6.66%	24,066 $1.86 Million
Q2 2018 Jul 31, 2018	SELL	$63.43 - $75.41 $235,959 - $280,525	-3,720 Reduced 12.61%	25,784 $1.9 Million
Q1 2018 Apr 23, 2018	SELL	$62.56 - $72.26 $40,351 - $46,607	-645 Reduced 2.14%	29,504 $1.92 Million
Q4 2017 Jan 23, 2018	SELL	$61.45 - $66.05 $673,492 - $723,908	-10,960 Reduced 26.66%	30,149 $1.95 Million
Q3 2017 Oct 25, 2017	BUY	$59.5 - $64.61 $2.45 Million - $2.66 Million	41,109	41,109 $2.58 Million

Others Institutions Holding BAX

# of Institutions

998

Shares Held

450M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Baxter International Inc Transaction History